Engineered human pluripotent stem cell derived cardiomyocyte platforms to detect cardiovascular safety liabilities
The development and screening of new chemical entities is often a lengthy and costly process, which relies heavily on the use of animal models for measuring pre-clinical drug safety liabilities. It has been estimated that it now costs pharmaceutical companies in excess of $1 billion and takes typica...
| Main Author: | Firth, Karl |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2017
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/42062/ |
Similar Items
Evaluating human induced pluripotent stem cell-derived cardiomyocytes for commercial drug testing
by: Katili, Puspita Anggraini
Published: (2020)
by: Katili, Puspita Anggraini
Published: (2020)
Human pluripotent stem cells derived-cardiomyocytes (hPSC-CMs) to assess the impact of drug- and gene-induced changes on cell function
by: Mohd Yusof, Nurul Ain Nasim
Published: (2020)
by: Mohd Yusof, Nurul Ain Nasim
Published: (2020)
Automation and scale-up of human induced pluripotent stem cell models of cardiovascular disease for drug screening
by: Crutchley, James E.B.
Published: (2016)
by: Crutchley, James E.B.
Published: (2016)
Development of multiparametric kinetic data and analytics workflows for the generation of an hiPSC-cardiomyocyte based cardiovascular model
by: Raniga, Kavita
Published: (2024)
by: Raniga, Kavita
Published: (2024)
Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform
by: Denning, Chris, et al.
Published: (2016)
by: Denning, Chris, et al.
Published: (2016)
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Building 3D architectures for cardiomyocytes
by: Turgut, Aylin
Published: (2021)
by: Turgut, Aylin
Published: (2021)
Can human pluripotent stem cell-derived cardiomyocytes advance understanding of muscular dystrophies?
by: Kalra, Spandan, et al.
Published: (2016)
by: Kalra, Spandan, et al.
Published: (2016)
Disease modeling hypertrophic cardiomyopathy using CRISPR/Cas9 genome editing technology in human pluripotent stem cell-derived cardiomyocytes
by: Mosqueira, Diogo
Published: (2018)
by: Mosqueira, Diogo
Published: (2018)
Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation
by: Dixon, James E., et al.
Published: (2014)
by: Dixon, James E., et al.
Published: (2014)
Current status of drug screening and disease modelling in human pluripotent stem cells
by: Rajamohan, Divya, et al.
Published: (2013)
by: Rajamohan, Divya, et al.
Published: (2013)
Cardiovascular safety liabilities of VEGFR-2 inhibitors
by: Pannucci, Patrizia
Published: (2024)
by: Pannucci, Patrizia
Published: (2024)
Tailoring mathematical models to stem-cell derived cardiomyocyte lines can improve predictions of drug-induced changes to their electrophysiology
by: Lei, Chon-Lok, et al.
Published: (2017)
by: Lei, Chon-Lok, et al.
Published: (2017)
The effects of undernutrition and dexamethasone treatment on cultured rat neonatal cardiomyocytes
by: Austin, Ruth Marie
Published: (2010)
by: Austin, Ruth Marie
Published: (2010)
In Vivo and in Vitro Toxicity Studies of Aqueous Extract of Mas Cotek (Ficus Deltoidea)
by: Mohd Saaya, Fazliana
Published: (2010)
by: Mohd Saaya, Fazliana
Published: (2010)
Efficacy of vitamin E and selenium supplementation in the prevention and treatment of signal grass (Brachiaria Decumbens Stapf) toxicity in sheep
by: Muhammad, Ajwad Awad
Published: (2011)
by: Muhammad, Ajwad Awad
Published: (2011)
A defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays
by: Patel, Asha K., et al.
Published: (2015)
by: Patel, Asha K., et al.
Published: (2015)
Drug-mediated shortening of action potentials in LQTS2 hiPSC-cardiomyocytes
by: Duncan, Gary, et al.
Published: (2017)
by: Duncan, Gary, et al.
Published: (2017)
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
by: Mosqueira, Diogo, et al.
Published: (2018)
by: Mosqueira, Diogo, et al.
Published: (2018)
The effect of hypoxia and reoxygenation on STAT3 regulation in potential cardiomyocyte models
by: Evans, Emma Louise
Published: (2012)
by: Evans, Emma Louise
Published: (2012)
Automated electrophysiological and pharmacological evaluation of human pluripotent stem cell-derived cardiomyocytes
by: Rajamohan, Divya, et al.
Published: (2016)
by: Rajamohan, Divya, et al.
Published: (2016)
Using human induced pluripotent stem cells to study the in vitro phenotype of the cardiac channelopathies
by: Duncan, Gary
Published: (2017)
by: Duncan, Gary
Published: (2017)
Understanding the genomic information of mycobacterium tuberculosis causing whole genome sequencing approach / Nur Azwin Ismail
by: Ismail, Nur Azwin
Published: (2015)
by: Ismail, Nur Azwin
Published: (2015)
Antibacterial activity and toxicity assay of biosynthesized silver nanoparticles by neem [azadirachta indica] leaves extract / Nur Amira Sariman
by: Sariman, Nur Amira
Published: (2020)
by: Sariman, Nur Amira
Published: (2020)
Toxicity studies of some medicinal plant extracts
by: Sukari, Mohd Aspollah, et al.
Published: (1989)
by: Sukari, Mohd Aspollah, et al.
Published: (1989)
MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo
by: Sala, L., et al.
Published: (2017)
by: Sala, L., et al.
Published: (2017)
Simplified footprint-free Cas9/CRISPR editing of cardiac-associated genes in human pluripotent stem cells
by: Kondrashov, Alexander, et al.
Published: (2018)
by: Kondrashov, Alexander, et al.
Published: (2018)
Concentration of heavy metals in drinking water and health risk from semi-urban area / Noorfazira Mohamed @ Busu
by: Mohamed @ Busu, Noorfazira
Published: (2017)
by: Mohamed @ Busu, Noorfazira
Published: (2017)
Element content of moss as possible air pollution indicator
around renewable energy plant / Zaliana Mohd Kanafi
by: Mohd Kanafi, Zaliana
Published: (2017)
by: Mohd Kanafi, Zaliana
Published: (2017)
Distributions of organochlorine pesticides in sediment and aquatic biota: Benzenehexachlorides (BHCS) / Azlina Mat Saad and Fadli Fizari Abu Hassan Asari
by: Mat Saad, Azlina, et al.
Published: (2019)
by: Mat Saad, Azlina, et al.
Published: (2019)
Antibacterial and toxicity properties of biosynthesized silver nanoparticles by lawsonia inermis extract / Nur Syazana Satteri
by: Satteri, Nur Syazana
Published: (2020)
by: Satteri, Nur Syazana
Published: (2020)
Characterization of M1A2 monoclonal antibody and in vitro cytotoxicity assessment
by: Bashokouh, Fatemeh
Published: (2012)
by: Bashokouh, Fatemeh
Published: (2012)
Improved reproductive performance through edible bird’s nest and its ameliorating properties in lead acetate toxicity of reproductive system in female rats
by: Albishtue, Abdulla Aaid Hadi
Published: (2018)
by: Albishtue, Abdulla Aaid Hadi
Published: (2018)
Alleviation of aflatoxin B1-induced gut toxicity via probiotic intervention through modulation of gut proteomes and microbiota
by: Liew, Winnie Pui Pui
Published: (2021)
by: Liew, Winnie Pui Pui
Published: (2021)
Anticoagulant activity and toxicity profiles of Melastoma malabathricum linn. leaf extract
by: Manicam, Caroline
Published: (2011)
by: Manicam, Caroline
Published: (2011)
Learning lessons from adverse drug reactions in children
by: Sammons, Helen, et al.
Published: (2016)
by: Sammons, Helen, et al.
Published: (2016)
Acute toxicity assessment of newly nanoformulated gallic acid-loaded graphene oxide using zebrafish embryonic model
by: Abdul Ghafor, Ahmad Ashraful Hadi
Published: (2022)
by: Abdul Ghafor, Ahmad Ashraful Hadi
Published: (2022)
Linking molecular targets to hypertrophic cardiomyopathy using genome-edited human induced pluripotent stem cell cardiomyocytes
by: Bodbin, S.E.
Published: (2022)
by: Bodbin, S.E.
Published: (2022)
Development of an in vitro model to investigate repeat ocular exposure
by: Wilkinson, Peter J.
Published: (2006)
by: Wilkinson, Peter J.
Published: (2006)
Anti-epileptic drug toxicity in children
by: Choonara, Imti
Published: (2018)
by: Choonara, Imti
Published: (2018)
Similar Items
-
Evaluating human induced pluripotent stem cell-derived cardiomyocytes for commercial drug testing
by: Katili, Puspita Anggraini
Published: (2020) -
Human pluripotent stem cells derived-cardiomyocytes (hPSC-CMs) to assess the impact of drug- and gene-induced changes on cell function
by: Mohd Yusof, Nurul Ain Nasim
Published: (2020) -
Automation and scale-up of human induced pluripotent stem cell models of cardiovascular disease for drug screening
by: Crutchley, James E.B.
Published: (2016) -
Development of multiparametric kinetic data and analytics workflows for the generation of an hiPSC-cardiomyocyte based cardiovascular model
by: Raniga, Kavita
Published: (2024) -
Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform
by: Denning, Chris, et al.
Published: (2016)